Health & Biotech
At Argent BioPharma, our mission is to revolutionize healthcare through pioneering innovation.
We go beyond traditional disease management by exploring the intricacies of the immune system and harnessing cutting-edge technologies in our research and development endeavors.
Through our commitment to advancing medical science, we aim to reshape the landscape of global healthcare by addressing unmet needs and offering hope to underserved populations worldwide.
Our vision encompasses becoming a leading biopharmaceutical company renowned for groundbreaking medical treatments. By embracing NanoPolyPharmacology, we strive to introduce impactful solutions that elevate standards within the life sciences industry. Our dedication extends to ensuring accessibility to innovative therapies for communities overlooked by conventional medical approaches, thereby bridging healthcare disparities on a global scale.
As we progress on this ambitious path, we invite you to follow our journey and be a part of a transformative shift in healthcare. At Argent BioPharma, we’re not just changing treatments; we’re changing lives.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
MGC Pharma achieves success in brain cancer treatment trial
Health & Biotech
Weed Week: ‘Lame duck’ US Congress set to vote on key cannabis bill
Health & Biotech
MGC Pharma closer to anti-inflammatory medicine for COVID after phase two clinical trial
Health & Biotech
MGC Pharma is on a roll, selling $225K in cannabis oil in the past four weeks
Health & Biotech
MGC Pharma’s cannabinoid medical spray passes pre-clinical FDA tests
Health & Biotech
MGC Pharma ships first Mercury Pharma THC products to Brazil
Health & Biotech
MGC Pharma launches CannEpil App for patients
Health & Biotech
COVID-19 patients recruited for MGC Pharma’s treatment
Health & Biotech
MGC Pharma fast-tracks London Stock Exchange listing
Health & Biotech
Pot Stocks: Althea tops the podium after becoming a licensed producer
Health & Biotech
North American fund backs MGC Pharmaceuticals to the tune of $15m
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma strengthens leadership team with new appointments
Health & Biotech
Aussie biotechs join crusade for COVID-19 cure
Health & Biotech